当前位置: X-MOL 学术 › Eye (Lond) › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Faricimab phase 3 DME trial significance of personalized treatment intervals (PTI) regime for future DME trials.
Eye (London, England) Pub Date : 2021-10-30 , DOI: 10.1038/s41433-021-01831-4
Ashish Sharma 1 , Nilesh Kumar 1, 2 , Nikulaa Parachuri 1, 3 , Dhatri Karanam 1 , Baruch D Kuppermann 4 , Francesco Bandello 5 , Carl D Regillo 6
Affiliation  



中文翻译:

Faricimab 3 期 DME 试验个性化治疗间隔 (PTI) 方案对未来 DME 试验的意义。

更新日期:2021-10-30
down
wechat
bug